Metropolis Healthcare Ltd

Over the last four decades, Metropolis Labs has established itself as a #trustedpartner and a #preferred brand by doctors across the country. As we continue to deepen our commitment to the #medicalcommunity, we are pleased to inform you that we have recently introduced #Metrobot, a one-of-a-kind chatbot designed specifically for doctors. Metropolis' Metrobot launch is an attempt to redefine doctor-provider engagement by eliminating the need for traditional call centres and offering doctors with a seamless WhatsApp-based chat platform. We have always been committed to leveraging technology, and this addition of Metrobot is a significant step forward in providing comprehensive care and empowering doctors to make informed decisions. Doctors can now access Metrobot via WhatsApp Chatbot number (93212 72717). Interested to know more about Metrobot? Do check out the article by clicking on the link below. Metropolis Leadership Team members Dr Kirti Chadha, Chief Scientific Officer and Group Head - CSR, and Mr. Kannan A, Chief Operating Officer formally inaugurated the Metrobot on #doctorday . #MetropolisLabs #Healthcare #ScientificExcellence #MetropolisScientificExpert #Technology #Growth #DoctorCommunication #Health #DiagnosticLeader #trustedpartner #preferred #medicalcommunity #Metrobot #doctorday #MetropolisLabs #Healthcare #ScientificExcellence #MetropolisScientificExpert #Technology #Growth #DoctorCommunication #Health #DiagnosticLeader

Type 1 and Type 2 diabetes are the most common types of diabetes that affect many people around the world. But do you know that there is also Type 3 diabetes? In an exclusive interaction with Onlymyhealth, Dr Bhavya Saxena, Consultant Pathologist at Metropolis Labs shares an in-depth overview of Type 3 Diabetes, its symptoms, and how it is diagnosed. Check out the article to know more. #MetropolisLab #Healthcare #DiabetesAwareness #Earlydetection #Diagnosis #MetropolisScientificExpert #CorporateWellness #Chronic #MetropolisLab #Healthcare #DiabetesAwareness #Earlydetection #Diagnosis #MetropolisScientificExpert #CorporateWellness #Chronic

Facing symptoms such as frequent urination, pelvic pain and blood in the urine or semen? Then you might want to get a #ProstateSpecificAntigen (PSA) test to rule out #ProstateCancer, which is one of the most common cancers among men. In this article covered by Onlymyhealth, Dr. Kunjan Lila, HOD - Surgical Pathology, Metropolis Labs joins other health experts in elaborating on the significance of PSA testing to detect prostate cancer and the need for early detection. #MetropolisLab #Healthcare #DiagnosticLeader #Healthtests #prostatecancerawareness #MetropolisScientificexpert #cancerdiagnosis #ProstateSpecificAntigen #ProstateCancer #MetropolisLab #Healthcare #DiagnosticLeader #Healthtests #prostatecancerawareness #MetropolisScientificexpert #cancerdiagnosis

Blood sugar result of less than 70mg/dL is usually considered low blood sugar, commonly known as hypoglycemia. It primarily affects people with diabetes, especially those who take insulin. Low blood sugar, much to everyone’s surprise, can also occur in non-diabetic patients. In an interview with Onlymyhealth editorial team, Dr Shefali Desai, AVP, Desai Metropolis Healthcare (Surat) discusses the causes and symptoms of low blood sugar and the different ways to manage it. #Bloodsugar #Bloodsugarcontrol #Diabetes #Hypoglycemia #Insulin #PreventativeHealth #Wellness #Truhealth #MetropolisLab #Healthcare #MetropolisScientificExperthttps://www.onlymyhealth.com/causes-of-low-blood-sugar-in-people-with-no-diabetes-1682935623 #Bloodsugar #Bloodsugarcontrol #Diabetes #Hypoglycemia #Insulin #PreventativeHealth #Wellness #Truhealth #MetropolisLab #Healthcare #MetropolisScientificExpert

At Metropolis Labs, we are committed to bringing new testing technologies that will assist doctors in making better clinical decisions and treatments, thereby enhancing the quality of patient care. In this direction, we are pleased to announce the #NextGenHLA Typing Test, which is powered by the complex molecular technology #nextgenerationsequencing (NGS). Metropolis' NextGen HLA Typing is a molecular test, which is performed for Bone Marrow Transplantation, also known as Hematopoietic Stem Cell Transplant (HSCT) & in Solid organ transplants such as Kidney transplants. This test aids in the identification of a suitable donor for bone marrow, cord blood, or organ transplant by analysing the Human Leukocyte Antigen (HLA) genes that a person has inherited from the parents. We believe that this test will help doctors find the right donors for their patients, resulting in successful transplants and higher survival rates. Metropolis Healthcare has established a centre of excellence for all transplant-related diagnostic services over the years, including the most comprehensive array of diagnostic tools, reports with more accurate interpretation, expert laboratory professionals, and subject matter specialists, making Metropolis a one-stop solution for all the transplant-related diagnostic needs. #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomicshttps://indiamedtoday.com/metropolis-launches-nextgen-hla-test-for-hsct-solid-organ-transplantation/ #NextGenHLA #nextgenerationsequencing #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomics

Check out this article in @ETHealth World authored by our #MetropolisScientificExpert Dr. Niranjan Patil, who explains how Whole Genome Sequencing by NGS Technology can aid in the diagnosis and management of drug-resistant tuberculosis. Dr. Niranjan Patil is the HOD and Scientific Business Head, Clinical Microbiology and Molecular Biology at Metropolis Healthcare's Global Reference Laboratory in Mumbai. #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencinghttps://health.economictimes.indiatimes.com/news/diagnostics/current-role-of-application-of-whole-genome-sequencing-by-ngs-technology-in-drug-resistant-tb-diagnosis-and-management/98965752#:~:text=Whole%20genome%20sequencing%20by%20NGS%20has%20tremendous%20potential%20for%20quickly,the%20WGS%20by%20NGS%20methodology #MetropolisScientificExpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencing

"The complexities of clinical presentations and the wide range of diagnostic tests available highlight the role of artificial intelligence (AI) and machine learning (ML) tools in supporting the National Tuberculosis Elimination Programme. It is critical to choose the right test/s for the prevailing clinical situation and to interpret the test results correctly," says Dr. Rohini Kelkar to ETHealthWorld. Check out this in-depth & insightful piece in which Dr. Rohini joins other scientific experts to share how digital technologies have been critical in enabling prompt and accurate tuberculosis diagnosis. #MetropolisScientificExpert Dr. Rohini Kelkar is the Senior Consultant, Infectious Diseases, Clinical Microbiology and Molecular Microbiology at Metropolis Healthcare Limited. At Metropolis, we all understand that underdiagnosis and multi-drug resistance are two aspects of Tuberculosis that require timely, accurate, and accessible diagnostic support. For more than a decade, Metropolis has provided the most comprehensive range of Tuberculosis tests, all of which are approved and recommended by WHO. The company has a dedicated Infectious Disease Division #Microxpert that has been assisting patients and clinicians from diagnosis to treatment by providing access to accurate lab results and WHO/NTEP approved advisory services via a novel model developed by Metropolis Healthcare's Innovation Cell. Metropolis has collaborated and worked with Central and State Government departments, Public Health departments, and Municipal Corporations across the country. Metropolis believes that its efforts in a variety of ways will help to strengthen the government's efforts to meet the TB elimination goals by 2025. Through CME Programs, national and international conferences, and information sharing, the company has been working to raise awareness among the medical community and laboratory practitioners about the latest trends and advancements in TB diagnosis. Furthermore, under the "Pradhan Mantri TB Mukt Abhiyan" initiative, the company has adopted 650 TB patients in Mumbai and has been providing nutritional support to them. #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing https://health.economictimes.indiatimes.com/news/diagnostics/eliminate-tb-by-2025-indias-pipe-dream/98976231 #MetropolisScientificExpert #Microxpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing

According to an Indian Council of Medical Research (ICMR) study, one in nine Indians are likely to develop cancer in their lifetime. It is not women who are being affected with cancer, men are also equally at risk with the cancer prevalence continually showing an upward trend among them. Here’s an article authored by Dr Shaikhali Barodawala, Scientific and Business Head, Integrated Oncopathology, Consultant and Head, Anatomic Pathology, Global Reference Laboratory, Metropolis Labs, in which he briefly highlights on the most common cancer symptoms for men in order to seek timely care and detection. #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/industry/minimizing-the-fear-of-unknown-mens-common-cancer-symptoms/98036165 #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeader

#DiagnosticOncology has come a long way courtesy of technological advancement, precision oncology, and companion diagnostics culminating into optimal patient care. This #worldcancerday2023 , Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs joins other leading Oncology specialists to share her views with The Times of India on the advancements in diagnosis and treatment of cancer. #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab #DiagnosticOncology #worldcancerday2023 #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab